Global Antibody Market Growth 2023-2029

Publisher Name :
Date: 04-Jan-2023
No. of pages: 114

Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called "antigens"). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler - scientists at the Roche-funded Basel Institute for Immunology - who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.

LPI (LP Information)' newest research report, the "Antibody Industry Forecast" looks at past sales and reviews total world Antibody sales in 2022, providing a comprehensive analysis by region and market sector of projected Antibody sales for 2023 through 2029. With Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antibody industry.

This Insight Report provides a comprehensive analysis of the global Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Antibody market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antibody and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antibody.

The global Antibody market size is projected to grow from US$ 8893.3 million in 2022 to US$ 12940 million in 2029; it is expected to grow at a CAGR of 12940 from 2023 to 2029.

Global Monoclonal Antibodies key players include Roche, Johnson and Johnson, Merck, Novartis, AbbVie, etc. Global top five players hold a share about 35%.

North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, having a total share about 45 percent.

In terms of product, IgG is the largest segment, with a share about 80%. And in terms of application, the largest application is Research, followed by Therapeutic and Diagnostic.

This report presents a comprehensive overview, market shares, and growth opportunities of Antibody market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

- IgM

- IgG

- IgA

- Other

Segmentation by application

- Therapeutic

- Research

- Diagnostic

The below companies that are profiled

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

- Roche

- Johnson and Johnson

- Merck

- Novartis

- AbbVie

- Amgen

- Pfizer

- Bayer

- Lilly

- Bristol-Myers Squibb

- GlaxoSmithKline

- Biogen

- AstraZeneca

- Sanofi

- Alexion Pharmaceuticals

- Seattle Genetics

Key Questions Addressed in this Report

What is the 10-year outlook for the global Antibody market?

What factors are driving Antibody market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Antibody market opportunities vary by end market size?

How does Antibody break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Global Antibody Market Growth 2023-2029

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antibody Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Antibody by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Antibody by Country/Region, 2018, 2022 & 2029
2.2 Antibody Segment by Type
2.2.1 IgM
2.2.2 IgG
2.2.3 IgA
2.2.4 Other
2.3 Antibody Sales by Type
2.3.1 Global Antibody Sales Market Share by Type (2018-2023)
2.3.2 Global Antibody Revenue and Market Share by Type (2018-2023)
2.3.3 Global Antibody Sale Price by Type (2018-2023)
2.4 Antibody Segment by Application
2.4.1 Therapeutic
2.4.2 Research
2.4.3 Diagnostic
2.5 Antibody Sales by Application
2.5.1 Global Antibody Sale Market Share by Application (2018-2023)
2.5.2 Global Antibody Revenue and Market Share by Application (2018-2023)
2.5.3 Global Antibody Sale Price by Application (2018-2023)
3 Global Antibody by Company
3.1 Global Antibody Breakdown Data by Company
3.1.1 Global Antibody Annual Sales by Company (2018-2023)
3.1.2 Global Antibody Sales Market Share by Company (2018-2023)
3.2 Global Antibody Annual Revenue by Company (2018-2023)
3.2.1 Global Antibody Revenue by Company (2018-2023)
3.2.2 Global Antibody Revenue Market Share by Company (2018-2023)
3.3 Global Antibody Sale Price by Company
3.4 Key Manufacturers Antibody Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antibody Product Location Distribution
3.4.2 Players Antibody Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Antibody by Geographic Region
4.1 World Historic Antibody Market Size by Geographic Region (2018-2023)
4.1.1 Global Antibody Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Antibody Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Antibody Market Size by Country/Region (2018-2023)
4.2.1 Global Antibody Annual Sales by Country/Region (2018-2023)
4.2.2 Global Antibody Annual Revenue by Country/Region (2018-2023)
4.3 Americas Antibody Sales Growth
4.4 APAC Antibody Sales Growth
4.5 Europe Antibody Sales Growth
4.6 Middle East & Africa Antibody Sales Growth
5 Americas
5.1 Americas Antibody Sales by Country
5.1.1 Americas Antibody Sales by Country (2018-2023)
5.1.2 Americas Antibody Revenue by Country (2018-2023)
5.2 Americas Antibody Sales by Type
5.3 Americas Antibody Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antibody Sales by Region
6.1.1 APAC Antibody Sales by Region (2018-2023)
6.1.2 APAC Antibody Revenue by Region (2018-2023)
6.2 APAC Antibody Sales by Type
6.3 APAC Antibody Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Antibody by Country
7.1.1 Europe Antibody Sales by Country (2018-2023)
7.1.2 Europe Antibody Revenue by Country (2018-2023)
7.2 Europe Antibody Sales by Type
7.3 Europe Antibody Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Antibody by Country
8.1.1 Middle East & Africa Antibody Sales by Country (2018-2023)
8.1.2 Middle East & Africa Antibody Revenue by Country (2018-2023)
8.2 Middle East & Africa Antibody Sales by Type
8.3 Middle East & Africa Antibody Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antibody
10.3 Manufacturing Process Analysis of Antibody
10.4 Industry Chain Structure of Antibody
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antibody Distributors
11.3 Antibody Customer
12 World Forecast Review for Antibody by Geographic Region
12.1 Global Antibody Market Size Forecast by Region
12.1.1 Global Antibody Forecast by Region (2024-2029)
12.1.2 Global Antibody Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Antibody Forecast by Type
12.7 Global Antibody Forecast by Application
13 Key Players Analysis
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Antibody Product Portfolios and Specifications
13.1.3 Roche Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Johnson and Johnson
13.2.1 Johnson and Johnson Company Information
13.2.2 Johnson and Johnson Antibody Product Portfolios and Specifications
13.2.3 Johnson and Johnson Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Johnson and Johnson Main Business Overview
13.2.5 Johnson and Johnson Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Antibody Product Portfolios and Specifications
13.3.3 Merck Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Novartis
13.4.1 Novartis Company Information
13.4.2 Novartis Antibody Product Portfolios and Specifications
13.4.3 Novartis Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Novartis Main Business Overview
13.4.5 Novartis Latest Developments
13.5 AbbVie
13.5.1 AbbVie Company Information
13.5.2 AbbVie Antibody Product Portfolios and Specifications
13.5.3 AbbVie Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 AbbVie Main Business Overview
13.5.5 AbbVie Latest Developments
13.6 Amgen
13.6.1 Amgen Company Information
13.6.2 Amgen Antibody Product Portfolios and Specifications
13.6.3 Amgen Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Amgen Main Business Overview
13.6.5 Amgen Latest Developments
13.7 Pfizer
13.7.1 Pfizer Company Information
13.7.2 Pfizer Antibody Product Portfolios and Specifications
13.7.3 Pfizer Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Pfizer Main Business Overview
13.7.5 Pfizer Latest Developments
13.8 Bayer
13.8.1 Bayer Company Information
13.8.2 Bayer Antibody Product Portfolios and Specifications
13.8.3 Bayer Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Bayer Main Business Overview
13.8.5 Bayer Latest Developments
13.9 Lilly
13.9.1 Lilly Company Information
13.9.2 Lilly Antibody Product Portfolios and Specifications
13.9.3 Lilly Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Lilly Main Business Overview
13.9.5 Lilly Latest Developments
13.10 Bristol-Myers Squibb
13.10.1 Bristol-Myers Squibb Company Information
13.10.2 Bristol-Myers Squibb Antibody Product Portfolios and Specifications
13.10.3 Bristol-Myers Squibb Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Bristol-Myers Squibb Main Business Overview
13.10.5 Bristol-Myers Squibb Latest Developments
13.11 GlaxoSmithKline
13.11.1 GlaxoSmithKline Company Information
13.11.2 GlaxoSmithKline Antibody Product Portfolios and Specifications
13.11.3 GlaxoSmithKline Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 GlaxoSmithKline Main Business Overview
13.11.5 GlaxoSmithKline Latest Developments
13.12 Biogen
13.12.1 Biogen Company Information
13.12.2 Biogen Antibody Product Portfolios and Specifications
13.12.3 Biogen Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Biogen Main Business Overview
13.12.5 Biogen Latest Developments
13.13 AstraZeneca
13.13.1 AstraZeneca Company Information
13.13.2 AstraZeneca Antibody Product Portfolios and Specifications
13.13.3 AstraZeneca Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 AstraZeneca Main Business Overview
13.13.5 AstraZeneca Latest Developments
13.14 Sanofi
13.14.1 Sanofi Company Information
13.14.2 Sanofi Antibody Product Portfolios and Specifications
13.14.3 Sanofi Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Sanofi Main Business Overview
13.14.5 Sanofi Latest Developments
13.15 Alexion Pharmaceuticals
13.15.1 Alexion Pharmaceuticals Company Information
13.15.2 Alexion Pharmaceuticals Antibody Product Portfolios and Specifications
13.15.3 Alexion Pharmaceuticals Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Alexion Pharmaceuticals Main Business Overview
13.15.5 Alexion Pharmaceuticals Latest Developments
13.16 Seattle Genetics
13.16.1 Seattle Genetics Company Information
13.16.2 Seattle Genetics Antibody Product Portfolios and Specifications
13.16.3 Seattle Genetics Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Seattle Genetics Main Business Overview
13.16.5 Seattle Genetics Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Antibody Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Antibody Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of IgM
Table 4. Major Players of IgG
Table 5. Major Players of IgA
Table 6. Major Players of Other
Table 7. Global Antibody Sales by Type (2018-2023) & (KG)
Table 8. Global Antibody Sales Market Share by Type (2018-2023)
Table 9. Global Antibody Revenue by Type (2018-2023) & ($ million)
Table 10. Global Antibody Revenue Market Share by Type (2018-2023)
Table 11. Global Antibody Sale Price by Type (2018-2023) & (USD/KG)
Table 12. Global Antibody Sales by Application (2018-2023) & (KG)
Table 13. Global Antibody Sales Market Share by Application (2018-2023)
Table 14. Global Antibody Revenue by Application (2018-2023)
Table 15. Global Antibody Revenue Market Share by Application (2018-2023)
Table 16. Global Antibody Sale Price by Application (2018-2023) & (USD/KG)
Table 17. Global Antibody Sales by Company (2018-2023) & (KG)
Table 18. Global Antibody Sales Market Share by Company (2018-2023)
Table 19. Global Antibody Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Antibody Revenue Market Share by Company (2018-2023)
Table 21. Global Antibody Sale Price by Company (2018-2023) & (USD/KG)
Table 22. Key Manufacturers Antibody Producing Area Distribution and Sales Area
Table 23. Players Antibody Products Offered
Table 24. Antibody Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Antibody Sales by Geographic Region (2018-2023) & (KG)
Table 28. Global Antibody Sales Market Share Geographic Region (2018-2023)
Table 29. Global Antibody Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Antibody Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Antibody Sales by Country/Region (2018-2023) & (KG)
Table 32. Global Antibody Sales Market Share by Country/Region (2018-2023)
Table 33. Global Antibody Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Antibody Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Antibody Sales by Country (2018-2023) & (KG)
Table 36. Americas Antibody Sales Market Share by Country (2018-2023)
Table 37. Americas Antibody Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Antibody Revenue Market Share by Country (2018-2023)
Table 39. Americas Antibody Sales by Type (2018-2023) & (KG)
Table 40. Americas Antibody Sales by Application (2018-2023) & (KG)
Table 41. APAC Antibody Sales by Region (2018-2023) & (KG)
Table 42. APAC Antibody Sales Market Share by Region (2018-2023)
Table 43. APAC Antibody Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Antibody Revenue Market Share by Region (2018-2023)
Table 45. APAC Antibody Sales by Type (2018-2023) & (KG)
Table 46. APAC Antibody Sales by Application (2018-2023) & (KG)
Table 47. Europe Antibody Sales by Country (2018-2023) & (KG)
Table 48. Europe Antibody Sales Market Share by Country (2018-2023)
Table 49. Europe Antibody Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Antibody Revenue Market Share by Country (2018-2023)
Table 51. Europe Antibody Sales by Type (2018-2023) & (KG)
Table 52. Europe Antibody Sales by Application (2018-2023) & (KG)
Table 53. Middle East & Africa Antibody Sales by Country (2018-2023) & (KG)
Table 54. Middle East & Africa Antibody Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Antibody Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Antibody Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Antibody Sales by Type (2018-2023) & (KG)
Table 58. Middle East & Africa Antibody Sales by Application (2018-2023) & (KG)
Table 59. Key Market Drivers & Growth Opportunities of Antibody
Table 60. Key Market Challenges & Risks of Antibody
Table 61. Key Industry Trends of Antibody
Table 62. Antibody Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Antibody Distributors List
Table 65. Antibody Customer List
Table 66. Global Antibody Sales Forecast by Region (2024-2029) & (KG)
Table 67. Global Antibody Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Antibody Sales Forecast by Country (2024-2029) & (KG)
Table 69. Americas Antibody Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Antibody Sales Forecast by Region (2024-2029) & (KG)
Table 71. APAC Antibody Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Antibody Sales Forecast by Country (2024-2029) & (KG)
Table 73. Europe Antibody Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Antibody Sales Forecast by Country (2024-2029) & (KG)
Table 75. Middle East & Africa Antibody Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Antibody Sales Forecast by Type (2024-2029) & (KG)
Table 77. Global Antibody Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Antibody Sales Forecast by Application (2024-2029) & (KG)
Table 79. Global Antibody Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Roche Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 81. Roche Antibody Product Portfolios and Specifications
Table 82. Roche Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2023)
Table 83. Roche Main Business
Table 84. Roche Latest Developments
Table 85. Johnson and Johnson Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 86. Johnson and Johnson Antibody Product Portfolios and Specifications
Table 87. Johnson and Johnson Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2023)
Table 88. Johnson and Johnson Main Business
Table 89. Johnson and Johnson Latest Developments
Table 90. Merck Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 91. Merck Antibody Product Portfolios and Specifications
Table 92. Merck Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2023)
Table 93. Merck Main Business
Table 94. Merck Latest Developments
Table 95. Novartis Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 96. Novartis Antibody Product Portfolios and Specifications
Table 97. Novartis Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2023)
Table 98. Novartis Main Business
Table 99. Novartis Latest Developments
Table 100. AbbVie Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 101. AbbVie Antibody Product Portfolios and Specifications
Table 102. AbbVie Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2023)
Table 103. AbbVie Main Business
Table 104. AbbVie Latest Developments
Table 105. Amgen Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 106. Amgen Antibody Product Portfolios and Specifications
Table 107. Amgen Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2023)
Table 108. Amgen Main Business
Table 109. Amgen Latest Developments
Table 110. Pfizer Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 111. Pfizer Antibody Product Portfolios and Specifications
Table 112. Pfizer Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2023)
Table 113. Pfizer Main Business
Table 114. Pfizer Latest Developments
Table 115. Bayer Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 116. Bayer Antibody Product Portfolios and Specifications
Table 117. Bayer Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2023)
Table 118. Bayer Main Business
Table 119. Bayer Latest Developments
Table 120. Lilly Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 121. Lilly Antibody Product Portfolios and Specifications
Table 122. Lilly Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2023)
Table 123. Lilly Main Business
Table 124. Lilly Latest Developments
Table 125. Bristol-Myers Squibb Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 126. Bristol-Myers Squibb Antibody Product Portfolios and Specifications
Table 127. Bristol-Myers Squibb Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2023)
Table 128. Bristol-Myers Squibb Main Business
Table 129. Bristol-Myers Squibb Latest Developments
Table 130. GlaxoSmithKline Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 131. GlaxoSmithKline Antibody Product Portfolios and Specifications
Table 132. GlaxoSmithKline Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2023)
Table 133. GlaxoSmithKline Main Business
Table 134. GlaxoSmithKline Latest Developments
Table 135. Biogen Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 136. Biogen Antibody Product Portfolios and Specifications
Table 137. Biogen Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2023)
Table 138. Biogen Main Business
Table 139. Biogen Latest Developments
Table 140. AstraZeneca Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 141. AstraZeneca Antibody Product Portfolios and Specifications
Table 142. AstraZeneca Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2023)
Table 143. AstraZeneca Main Business
Table 144. AstraZeneca Latest Developments
Table 145. Sanofi Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 146. Sanofi Antibody Product Portfolios and Specifications
Table 147. Sanofi Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2023)
Table 148. Sanofi Main Business
Table 149. Sanofi Latest Developments
Table 150. Alexion Pharmaceuticals Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 151. Alexion Pharmaceuticals Antibody Product Portfolios and Specifications
Table 152. Alexion Pharmaceuticals Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2023)
Table 153. Alexion Pharmaceuticals Main Business
Table 154. Alexion Pharmaceuticals Latest Developments
Table 155. Seattle Genetics Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 156. Seattle Genetics Antibody Product Portfolios and Specifications
Table 157. Seattle Genetics Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2023)
Table 158. Seattle Genetics Main Business
Table 159. Seattle Genetics Latest Developments
List of Figures
Figure 1. Picture of Antibody
Figure 2. Antibody Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antibody Sales Growth Rate 2018-2029 (KG)
Figure 7. Global Antibody Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Antibody Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of IgM
Figure 10. Product Picture of IgG
Figure 11. Product Picture of IgA
Figure 12. Product Picture of Other
Figure 13. Global Antibody Sales Market Share by Type in 2022
Figure 14. Global Antibody Revenue Market Share by Type (2018-2023)
Figure 15. Antibody Consumed in Therapeutic
Figure 16. Global Antibody Market: Therapeutic (2018-2023) & (KG)
Figure 17. Antibody Consumed in Research
Figure 18. Global Antibody Market: Research (2018-2023) & (KG)
Figure 19. Antibody Consumed in Diagnostic
Figure 20. Global Antibody Market: Diagnostic (2018-2023) & (KG)
Figure 21. Global Antibody Sales Market Share by Application (2022)
Figure 22. Global Antibody Revenue Market Share by Application in 2022
Figure 23. Antibody Sales Market by Company in 2022 (KG)
Figure 24. Global Antibody Sales Market Share by Company in 2022
Figure 25. Antibody Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Antibody Revenue Market Share by Company in 2022
Figure 27. Global Antibody Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Antibody Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Antibody Sales 2018-2023 (KG)
Figure 30. Americas Antibody Revenue 2018-2023 ($ Millions)
Figure 31. APAC Antibody Sales 2018-2023 (KG)
Figure 32. APAC Antibody Revenue 2018-2023 ($ Millions)
Figure 33. Europe Antibody Sales 2018-2023 (KG)
Figure 34. Europe Antibody Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Antibody Sales 2018-2023 (KG)
Figure 36. Middle East & Africa Antibody Revenue 2018-2023 ($ Millions)
Figure 37. Americas Antibody Sales Market Share by Country in 2022
Figure 38. Americas Antibody Revenue Market Share by Country in 2022
Figure 39. Americas Antibody Sales Market Share by Type (2018-2023)
Figure 40. Americas Antibody Sales Market Share by Application (2018-2023)
Figure 41. United States Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Antibody Sales Market Share by Region in 2022
Figure 46. APAC Antibody Revenue Market Share by Regions in 2022
Figure 47. APAC Antibody Sales Market Share by Type (2018-2023)
Figure 48. APAC Antibody Sales Market Share by Application (2018-2023)
Figure 49. China Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Antibody Sales Market Share by Country in 2022
Figure 57. Europe Antibody Revenue Market Share by Country in 2022
Figure 58. Europe Antibody Sales Market Share by Type (2018-2023)
Figure 59. Europe Antibody Sales Market Share by Application (2018-2023)
Figure 60. Germany Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Antibody Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Antibody Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Antibody Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Antibody Sales Market Share by Application (2018-2023)
Figure 69. Egypt Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Antibody in 2022
Figure 75. Manufacturing Process Analysis of Antibody
Figure 76. Industry Chain Structure of Antibody
Figure 77. Channels of Distribution
Figure 78. Global Antibody Sales Market Forecast by Region (2024-2029)
Figure 79. Global Antibody Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Antibody Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Antibody Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Antibody Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Antibody Revenue Market Share Forecast by Application (2024-2029)
  • Global Antibody Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 136
    According to our LPI (LP Information) latest study, the global Antibody market size was valued at US$ 8893.3 million in 2023. With growing demand in downstream market, the Antibody is forecast to a readjusted size of US$ 12940 million by 2030 with a CAGR of 5.5% during review period. The research report highlights the growth potential of the global Antibody market. Antibody are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......
  • Global Antibody Production Market Status and Outlook 2023-2028
    Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 121
    Antibody production involves preparation of antigen samples and their safe injection into laboratory or farm animals so as to evoke high expression levels of antigen-specific antibodies in the serum, which can then be recovered from the animal. Polyclonal antibodies are recovered directly from serum (bleeds). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (mil......
  • Global Antibody Production Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Antibody Production market: According to our latest research, the global Antibody Production market looks promising in the next 5 years. As of 2022, the global Antibody Production market was estimated at USD 9193.37 million, and it's anticipated to reach USD 17140.24 million in 2028, with a CAGR of 10.94% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global ......
  • Global Antibody Production Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 117
    Report Overview: The Global Antibody Production Market Size was estimated at USD 8847.90 million in 2022 and is projected to reach USD 14207.79 million by 2029, exhibiting a CAGR of 7.00% during the forecast period. This report provides a deep insight into the global Antibody Production market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key mark......
  • Global Anti-CD20 Monoclonal Antibodies Professional Survey Report 2023, Forecast to 2028
    Published: 30-Nov-2023        Price: US 3280 Onwards        Pages: 100
    Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......
  • Global Anti-CD20 Monoclonal Antibodies Market Research Report 2023, Forecast to 2028
    Published: 30-Nov-2023        Price: US 2680 Onwards        Pages: 165
    Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......
  • Monoclonal Antibody Industry Forecasts - China Focus
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 92
    This study focuses on China's Monoclonal Antibody industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services.......
  • Monoclonal Antibody Companies in China
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 73
    This study focuses on China's Monoclonal Antibody industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions......
  • Monoclonal Antibody Markets in China
    Published: 27-Nov-2023        Price: US 4000 Onwards        Pages: 219
    China's demand for Monoclonal Antibody has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, i......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs